NPR February 29, 2024
Rob Stein

NEAR BLACKSBURG, Va. — It’s a crisp, clear winter day as I drive down a winding two-lane road through the foothills of the Blue Ridge Mountains in southwest Virginia and turn onto an unmarked gravel driveway.

At the end of the drive, I meet David Ayares, who runs Revivicor Inc., a biotech company based in Blacksburg, Virginia.

Ayares has invited me to be the first journalist to tour the company’s research farm, which is on the forefront of trying to realize a long-sought goal: using cloned farm animals to provide kidneys, hearts, livers and other organs to save thousands of people who need transplants.

“It’s exciting. We’ve been working on this for more than 20 years. And it’s no longer...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
Cofactor AI Nabs $4M to Combat Hospital Claim Denials with AI
Shifting Our Healthcare Delivery Model from Reactive to Proactive
Trinity Health back in the black in Q1
109 hospitals receiving new Medicare-backed residency slots
Mayo develops new AI tools

Share This Article